Table 3.
Spearman Correlations Between Traditional BTMs and BMDs at Various Sites Among All Participants Studied.
Lumbar Spine (L1–L4) (g/cm2) | Femoral Neck (g/cm2) | Trochanter (g/cm2) | Total Hip (g/cm2) | ||
---|---|---|---|---|---|
BALP (µg/mL) | γ | −0.141* | −0.276* | −0.261* | −0.203* |
P | 0.013 | <0.001 | <0.001 | <0.001 | |
OC (ng/mL) | γ | −0.405* | −0.464* | −0.493* | −0.441* |
P | <0.001 | <0.001 | <0.001 | <0.001 | |
P1NP (ng/mL) | γ | −0.442* | −0.457* | −0.494* | −0.458* |
P | <0.001 | <0.001 | <0.001 | <0.001 | |
β-CTX (ng/mL) | γ | −0.153* | −0.316* | −0.375* | −0.286* |
P | 0.007 | <0.001 | <0.001 | <0.001 | |
TRACP 5b (U/L) | γ | −0.133* | −0.241* | −0.228* | −0.157* |
P | 0.019 | <0.00 | <0.001 | 0.005 |
Note: *Statistical significance at the P < 0.05 level.
Abbreviations: BTMs, bone turnover markers; BMDs, bone mineral densities; BALP, bone-specific alkaline phosphatase; OC, osteocalcin; P1NP, procollagen type 1 N-terminal propeptide; β-CTX, β cross-linked C-telopeptide of type I collagen; TRACP 5b, tartrate-resistant acid phosphatase 5b.